Mobile prostate cancer screening unit hits the streets of NYC

A new mobile prostate cancer screening unit has just been launched by Mount Sinai Health in New York City. 

Also known as the Mount Sinai Robert F. Smith Mobile Prostate Cancer Screening Unit, the vehicle was developed with the intention of increasing access to screening and supporting prostate health in the Black community, which has a disproportionately high incidence of prostate cancer compared to white men. The van is equipped to complete several screening mechanisms, including prostate-specific antigen tests, digital rectal exams, ultrasound and genomics testing. 

“The Robert F. Smith Mobile Prostate Cancer Screening Unit will be an invaluable service for the community, allowing us to meet our patients where they are,” Ash Tewari, MBBS, Chair of Urology at the Mount Sinai Health System and leader of the mobile initiative, said in a statement. “Our goal is that with increased education, awareness, and access to testing, we can help detect prostate cancer early, save lives, and close the gaps in high-risk diagnostic and fatality rates.” 

With the help of community health partners, the Mount Sinai Health System intends to raise awareness about prostate cancer and the screening capabilities of the mobile unit in Black neighborhoods throughout New York City. Additionally, they are assisting in setting up prostate cancer screening appointments and scheduling follow-ups with urologists as needed.  

The mobile unit comes as the result of a $3.8 million donation from philanthropist Robert F. Smith, chairman and CEO of Vista Equity Partners. 

“With Black men at an increased risk of both being diagnosed with and dying from prostate cancer, getting these life-saving resources for testing and treatment into our communities has never been more urgent,” Smith said in a statement. “I am proud to support Mount Sinai in these efforts to ensure we do not continue to lose far too many husbands, fathers, uncles, brothers, sons, and friends to this disease. This mobile screening unit will bring awareness and care right into the communities where they are most needed.” 

The unit is set to begin visiting communities in New York City on May 14. Community events can be scheduled by calling 646-531-8092 or emailing prostatecancer@mountsinai.org. For more information, visit https://www.mountsinai.org/care/cancer/services/prostate/mobile-screening. 

More on prostate cancer screening: 

New MRI technique 'lights up' prostate cancer

FDA approves new radioligand therapy for PSMA positive metastatic prostate cancer

New radiotracer that detects prostate cancer recurrence produces 'stunning' results

Is PET/CT or multiparametric MRI best for detecting prostate cancer? New research offers guidance

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup